Bone Marrow Transplantation - Table of Contents alert Volume 52 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 52, Issue 3 (March 2017) In this issue Perspective Reviews Special Report Original Articles Letters to the Editor Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Perspective Top One or two umbilical cord blood cell units? Caveat emptor J Sanz and R P Gale Bone Marrow Transplant 2017 52: 341-343; advance online publication, January 9, 2017; 10.1038/bmt.2016.277 Full Text Reviews Top Inhibition of FLT3 in AML: a focus on sorafenib A Antar, Z K Otrock, J El-Cheikh, M A Kharfan-Dabaja, G Battipaglia, R Mahfouz, M Mohty and A Bazarbachi Bone Marrow Transplant 2017 52: 344-351; advance online publication, October 24, 2016; 10.1038/bmt.2016.251 Abstract | Full Text Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy? P Dhakal and V R Bhatt Bone Marrow Transplant 2017 52: 352-356; advance online publication, October 24, 2016; 10.1038/bmt.2016.253 Abstract | Full Text Special Report Top The EBMT–ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis T Ruutu, A Gratwohl, D Niederwieser, T de Witte, S van der Werf, A van Biezen, M Mohty, N Kröger, A Rambaldi, E McGrath, A Sureda, G Basak, H Greinix and R F Duarte on behalf of the EBMT Complications and Quality of Life Working Party and the European LeukemiaNet Stem Cell Transplantation Work Package Bone Marrow Transplant 2017 52: 357-362; advance online publication, November 28, 2016; 10.1038/bmt.2016.298 Abstract | Full Text Original Articles Top ACUTE LEUKEMIA An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication V V Maka, L-P Koh, C Diong, Y-T Goh, S Gopalakrishnan, A Ho, W Hwang, M Koh, F Lim, Z-Y Lim, Y Loh, M Poon, D R Del Rosario, B-C Tai, L-K Tan, P Tan and Y-C Linn Bone Marrow Transplant 2017 52: 363-371; advance online publication, October 31, 2016; 10.1038/bmt.2016.286 Abstract | Full Text CHRONIC LEUKEMIA Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation M van Gelder, L C de Wreede, M Bornhäuser, D Niederwieser, M Karas, N S Anderson, M Gramatzki, P Dreger, M Michallet, E Petersen, D Bunjes, M Potter, D Beelen, J J Cornelissen, I Yakoub-Agha, N H Russell, J Finke, H Schoemans, A Vitek, Á Urbano-Ispízua, D Blaise, L Volin, P Chevallier, D Caballero, H Putter, A van Biezen, A Henseler, S Schönland, N Kröger and J Schetelig on behalf of the Chronic Malignancy Working Party Bone Marrow Transplant 2017 52: 372-380; advance online publication, December 12, 2016; 10.1038/bmt.2016.282 Abstract | Full Text APLASTIC ANEMIA Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia L P Xu, X H Zhang, F R Wang, X D Mo, T T Han, W Han, Y H Chen, Y Y Zhang, J Z Wang, C H Yan, Y Q Sun, S N Zuo and X J Huang Bone Marrow Transplant 2017 52: 381-387; advance online publication, December 12, 2016; 10.1038/bmt.2016.281 Abstract | Full Text INHERITED AND GENETIC DISORDERS Pregnancy outcome following hematopoietic cell transplantation for thalassemia major S Santarone, A Natale, P Olioso, D Onofrillo, C D’Incecco, G Parruti and P Di Bartolomeo Bone Marrow Transplant 2017 52: 388-393; advance online publication, November 7, 2016; 10.1038/bmt.2016.287 Abstract | Full Text GRAFT SOURCE ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation P Solves, N Carpio, C Carretero, J I Lorenzo, J Sanz, I Gómez, F López-Chuliá, M J Arilla, A I Regadera, P Montesinos, G F Sanz and M Á Sanz Bone Marrow Transplant 2017 52: 394-399; advance online publication, October 31, 2016; 10.1038/bmt.2016.264 Abstract | Full Text GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes Y-B Chen, T Wang, M T Hemmer, C Brady, D R Couriel, A Alousi, J Pidala, A Urbano-Ispizua, S W Choi, T Nishihori, T Teshima, Y Inamoto, B Wirk, D I Marks, H Abdel-Azim, L Lehmann, L Yu, M Bitan, M S Cairo, M Qayed, R Salit, R P Gale, R Martino, S Jaglowski, A Bajel, B Savani, H Frangoul, I D Lewis, J Storek, M Askar, M A Kharfan-Dabaja, M Aljurf, O Ringden, R Reshef, R F Olsson, S Hashmi, S Seo, T R Spitzer, M L MacMillan, A Lazaryan, S R Spellman, M Arora and C S Cutler Bone Marrow Transplant 2017 52: 400-408; advance online publication, December 12, 2016; 10.1038/bmt.2016.265 Abstract | Full Text Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation Y-R Ma, L-P Xu, X-H Zhang, C-H Yan, Y Wang, F-R Wang, J-Z Wang, Y Chen, W Han, Y-H Chen, H Chen, K-Y Liu and X-J Huang Bone Marrow Transplant 2017 52: 409-414; advance online publication, October 31, 2016; 10.1038/bmt.2016.283 Abstract | Full Text TRANSPLANT TOXICITIES The clinical value of biomarkers in respiratory complications in hematopoietic SCT C M Lucena, M Rovira, A Gabarrús, X Filella, C Martínez, R Domingo, A Torres and C Agustí Bone Marrow Transplant 2017 52: 415-422; advance online publication, October 31, 2016; 10.1038/bmt.2016.280 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil S Terakura, A Wake, Y Inamoto, M Murata, R Sakai, T Yamaguchi, S Takahashi, N Uchida, Y Onishi, K Ohashi, Y Ozawa, H Kanamori, H Yamaguchi, T Fukuda, T Ichinohe, M Takanashi, Y Atsuta and T Teshima for the Japan Society for Hematopoietic Cell Transplantation GvHD working group Bone Marrow Transplant 2017 52: 423-430; advance online publication, December 12, 2016; 10.1038/bmt.2016.255 Abstract | Full Text Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy Y Björk, E Smith Knutsson, C Ankarberg-Lindgren, A-K Broman, I Andersson, L Björkman, J Magnusson, K Bergmark, H Anderson, P-O Andersson and M Brune Bone Marrow Transplant 2017 52: 431-437; advance online publication, December 12, 2016; 10.1038/bmt.2016.268 Abstract | Full Text Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation M A Kharfan-Dabaja, R Parody, J Perkins, O Lopez-Godino, L Lopez-Corral, L Vazquez, D Caballero, J Falantes, J Shapiro, G Ortí, P Barba, D Valcárcel, A Esquirol, R Martino, J L Piñana, C Solano, A Tsalatsanis, J Pidala, C Anasetti and J A Perez-Simón Bone Marrow Transplant 2017 52: 438-444; advance online publication, November 7, 2016; 10.1038/bmt.2016.269 Abstract | Full Text Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemia P Tsirigotis, M Liga, K Gkirkas, M Stamouli, E Triantafyllou, M Marangos, I Pessach, A Sarantopoulos, N Spyridis and A Spyridonidis Bone Marrow Transplant 2017 52: 445-451; advance online publication, December 12, 2016; 10.1038/bmt.2016.272 Abstract | Full Text Letters to the Editor Top Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation OPEN J Radford, P McKay, R Malladi, R Johnson, A Bloor, F Percival, A Sureda and K S Peggs Bone Marrow Transplant 2017 52: 452-454; advance online publication, January 16, 2017; 10.1038/bmt.2016.244 Full Text Etoposide phosphate hypersensitivity overcome using a desensitisation programme enabling optimal therapy for relapsed Hodgkin lymphoma P Polistena, Q Tran, M Cirillo, M O'Sullivan and D Purtill Bone Marrow Transplant 2017 52: 455-456; advance online publication, October 31, 2016; 10.1038/bmt.2016.288 Full Text Aggressive skin cancer in chronic GvHD after allogeneic hematopoietic cell transplantation J S Lehman, C L Baum, E Moore, D Price, S Toosi and S K Hashmi Bone Marrow Transplant 2017 52: 457-458; advance online publication, November 14, 2016; 10.1038/bmt.2016.290 Full Text Evidence for CD19B–CD8T cell interactions in blood and tissues from patients with GvHD OPEN S Deola, C Cugno, P Comoli, I Guido, L Rubert, M Zecca, D Zanolini, A Follenzi, M Langes, G Negri, M Tauber, I Pusceddu, I Cavattoni, M Svaldi, G U Grigoleit, E Baumeister, E Wang, S Rutella and F M Marincola Bone Marrow Transplant 2017 52: 459-462; advance online publication, November 7, 2016; 10.1038/bmt.2016.294 Full Text Hematopoietic stem cell transplantation in FANCJ/BRIP1 fanconi anemia A Alsultan, M Essa and R Alsudairy Bone Marrow Transplant 2017 52: 463-465; advance online publication, November 21, 2016; 10.1038/bmt.2016.296 Full Text If the gut works, use it! But does the gut work in gastrointestinal GvHD? B S van der Meij, N J Wierdsma, J J W M Janssen, N E P Deutz and O J Visser Bone Marrow Transplant 2017 52: 466-469; advance online publication, December 12, 2016; 10.1038/bmt.2016.297 Full Text Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission W-Z Cai, J-N Cen, J Chen, F Chen, C-C Fu, Y Han, Z-M Jin, X Ma, M Miao, H-Y Qiu, X-W Tang, S-L Xue, A-N Sun, S-N Chen and D-P Wu Bone Marrow Transplant 2017 52: 470-472; advance online publication, January 16, 2017; 10.1038/bmt.2016.307 Full Text Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia F Buccisano, L Maurillo, A Piciocchi, M I Del Principe, A Picardi, R Cerretti, L Cudillo, G De Angelis, C Sarlo, M Cefalo, C Ditto, A Di Veroli, B Mariotti, D Nasso, E De Bellis, G Del Poeta, M T Voso, G Sconocchia, F Lo Coco, W Arcese, S Amadori and A Venditti Bone Marrow Transplant 2017 52: 473-475; advance online publication, December 12, 2016; 10.1038/bmt.2016.308 Full Text Pretransplant chest computed tomography screening in asymptomatic patients with leukemia and myelodysplastic syndrome Z El Boghdadly, B Oran, Y Jiang, G Rondon, R Champlin and D P Kontoyiannis Bone Marrow Transplant 2017 52: 476-479; advance online publication, December 12, 2016; 10.1038/bmt.2016.309 Full Text Polyvalent immunoglobulins, platelet lysate and lenalidomide: cocktail for polyfunctional NK cells expansion for multiple myeloma H Trébéden-Negre, V Vieillard, M Rosenzwajg, L Garderet, M Cherai, S Nguyen-Quoc, M L Tanguy and F Norol Bone Marrow Transplant 2017 52: 480-483; advance online publication, December 12, 2016; 10.1038/bmt.2016.311 Full Text Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study H Fujiwara, S Fuji, A Wake, K Kato, Y Takatsuka, T Fukuda, J Taguchi, N Uchida, T Miyamoto, M Hidaka, Y Miyazaki, T Tomoyose, M Onizuka, M Takanashi, T Ichinohe, Y Atsuta, A Utsunomiya and ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation Bone Marrow Transplant 2017 52: 484-488; advance online publication, January 9, 2017; 10.1038/bmt.2016.313 Full Text Publish or perish: can a ‘Write Club’ help junior faculty be more productive? S J Lee, G-S Cheng, T S Hyun, R B Salit, E T Loggers, D Egan, M Shadman, L Connelly-Smith, E F Krakow and M E Flowers Bone Marrow Transplant 2017 52: 489-490; advance online publication, December 12, 2016; 10.1038/bmt.2016.314 Full Text BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications C Fair, R Shanley, J Rogosheske, A Lazaryan, B McClune, C G Brunstein and V Bachanova Bone Marrow Transplant 2017 52: 491-493; advance online publication, January 9, 2017; 10.1038/bmt.2016.316 Full Text Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT A Colecchia, G Marasco, F Ravaioli, K Kleinschmidt, R Masetti, A Prete, A Pession and D Festi Bone Marrow Transplant 2017 52: 494-497; advance online publication, December 12, 2016; 10.1038/bmt.2016.320 Full Text Corrigendum Top Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation L Boudin, A Gonçalves, R Sabatier, J Moretta, P Sfumato, P Asseeva, D Livon, F Bertucci, J-M Extra, C Tarpin, G Houvenaeghel, E Lambaudie, A Tallet, M Resbeut, H Sobol, E Charafe-Jauffret, B Calmels, C Lemarie, J-M Boher, P Viens, F Eisinger and C Chabannon Bone Marrow Transplant 2017 52: 498; advance online publication, January 16, 2017; 10.1038/bmt.2016.291 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.